| Document and Entity Information | 6 Months Ended | |
| Jun. 30, 2014 | Aug. 18, 2014 | |
| Document And Entity Information | ' | ' |
| Entity Registrant Name | 'CANFIELD MEDICAL SUPPLY, INC. | ' |
| Entity Central Index Key | '0001553788 | ' |
| Document Type | '10-Q | ' |
| Document Period End Date | 30-Jun-14 | ' |
| Amendment Flag | 'false | ' |
| Current Fiscal Year End Date | '--12-31 | ' |
| Is Entity a Well-known Seasoned Issuer? | 'No | ' |
| Is Entity a Voluntary Filer? | 'No | ' |
| Is Entity's Reporting Status Current? | 'Yes | ' |
| Entity Filer Category | 'Smaller Reporting Company | ' |
| Entity Common Stock, Shares Outstanding | ' | 10,027,200 |
| Document Fiscal Period Focus | 'Q2 | ' |
| Document Fiscal Year Focus | '2014 | ' |
| Condensed Balance Sheets (USD $) | Jun. 30, 2014 | Dec. 31, 2013 |
| Current Assets | ' | ' |
| Cash | $51,701 | $669 |
| Accounts receivable | 39,987 | 30,921 |
| Inventory | 18,188 | 12,542 |
| Total Current Assets | 109,876 | 44,132 |
| Equipment, net of accumulated depreciation of $4,405 and $1,912 | 21,364 | 23,857 |
| Total Assets | 131,240 | 67,989 |
| Current Liabilities | ' | ' |
| Accounts payable | 39,542 | 43,043 |
| Related parties notes payable | ' | 8,500 |
| Line of credit | 81,000 | 82,500 |
| Current portion of long-term debt | 3,593 | 3,537 |
| Total Current Liabilities | 124,135 | 137,580 |
| Long-term debt | 16,057 | 17,784 |
| Total Liabilities | 140,192 | 155,364 |
| Preferred stock, no par value; 5,000,000 shares authorized; no shares issued and outstanding | ' | ' |
| Common stock, no par value; 100,000,000 shares authorized; 10,027,200 (2014) and 9,750,800 (2013) shares issued and outstanding | $118,515 | $49,415 |
| Accumulated deficit | -127,467 | -136,790 |
| Total Stockholders' Deficit | -8,952 | -87,375 |
| Total Liabilities and Stockholders' Deficit | $131,240 | $67,989 |
| Condensed Balance Sheets (Parenthetical) (USD $) | Jun. 30, 2014 | Dec. 31, 2013 |
| Statement of Financial Position [Abstract] | ' | ' |
| Preferred stock, par value | $0 | $0 |
| Preferred stock, authorized shares | 5,000,000 | 5,000,000 |
| Preferred stock, issued shares | ' | ' |
| Preferred stock, outstanding shares | ' | ' |
| Common stock, par value | $0 | $0 |
| Common stock, authorized shares | 100,000,000 | 100,000,000 |
| Common stock, issued shares | 10,027,200 | 9,750,800 |
| Common stock, outstanding shares | 10,027,200 | 9,750,800 |
| Net of depreciation on equipment | $4,405 | $1,912 |
| Condensed Statements of Operations (USD $) | 3 Months Ended | 6 Months Ended | ||
| Jun. 30, 2014 | Jun. 30, 2013 | Jun. 30, 2014 | Jun. 30, 2013 | |
| Income Statement [Abstract] | ' | ' | ' | ' |
| Sales (net of returns) | $143,202 | $82,366 | $299,841 | $155,720 |
| Cost of goods sold | 59,535 | 40,847 | 131,562 | 69,872 |
| Gross profit | 83,667 | 41,519 | 168,279 | 85,848 |
| Operating expenses: | ' | ' | ' | ' |
| General and administrative | 84,886 | 47,487 | 152,936 | 97,402 |
| Depreciation | 1,297 | ' | 2,493 | ' |
| Total operating expenses | 86,183 | 47,487 | 155,429 | 97,402 |
| Income (loss) from operations | -2,516 | -5,968 | 12,850 | -11,554 |
| Other income (expense): | ' | ' | ' | ' |
| Interest income | 18 | ' | 18 | ' |
| Interest expense | -2,603 | -1,076 | -3,545 | -1,657 |
| Total Other income (expense) | -2,585 | -1,076 | -3,527 | -1,657 |
| Income (loss) before provision for income taxes | -5,101 | -7,044 | 9,323 | -13,211 |
| Provision for income tax | ' | ' | ' | ' |
| Net income (loss) | ($5,101) | ($7,044) | $9,323 | ($13,211) |
| Net income (loss) per share (basic and fully diluted) | $0 | $0 | $0 | $0 |
| Weighted average number of common shares outstanding | 9,874,366 | 9,500,000 | 9,989,420 | 9,500,000 |
| Condensed Statements of Cash Flows (USD $) | 6 Months Ended | |
| Jun. 30, 2014 | Jun. 30, 2013 | |
| Cash Flows From Operating Activities: | ' | ' |
| Net income (loss) | $9,323 | ($13,211) |
| Adjustments to reconcile net income (loss) to net cash provided by (used for) operating activities: | ' | ' |
| Depreciation | 2,493 | ' |
| Accounts receivable | -9,066 | -2,038 |
| Inventory | -5,646 | ' |
| Accounts payable | -3,501 | 7,909 |
| Net cash provided by (used for) operating activities | -6,397 | -7,340 |
| Cash Flows From Investing Activities: | ' | ' |
| Net cash provided by (used for) investing activities | ' | ' |
| Cash Flows From Financing Activities: | ' | ' |
| Payments on line of credit | -1,500 | -1,500 |
| Proceeds from notes payable, related parties | ' | 7,500 |
| Repayments of notes payable, related parties | -8,500 | ' |
| Payments on long-term debt | -1,671 | ' |
| Proceeds from sales of common stock | 69,100 | ' |
| Net cash provided by (used for) financing activities | 57,429 | 6,000 |
| Net Increase (Decrease) in Cash | 51,032 | -1,340 |
| Cash At The Beginning Of The Period | 669 | 7,352 |
| Cash At The End Of The Period | 51,701 | 6,012 |
| Schedule Of Non-Cash Investing And Financing Activities | ' | ' |
| Supplemental Disclosure | ' | ' |
| Cash paid for interest | 3,545 | 1,657 |
| Cash paid for income taxes | ' | ' |
| 1 ORGANIZATION AND OPERATIONS | 6 Months Ended |
| Jun. 30, 2014 | |
| Organization, Consolidation and Presentation of Financial Statements [Abstract] | ' |
| ORGANIZATION AND OPERATIONS | ' |
| NOTE 1. ORGANIZATION AND OPERATIONS | |
| Canfield Medical Supply, Inc. (the "Company"), was incorporated in the State of Ohio on September 3, 1992 and changed domicile to Colorado on April 18, 2012. The Company sells medical supplies to clinics, hospitals and other end users. |
| 2 SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | 6 Months Ended |
| Jun. 30, 2014 | |
| Organization, Consolidation and Presentation of Financial Statements [Abstract] | ' |
| SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | ' |
| NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | |
| Interim Financial Statements | |
| The accompanying financial statements have been prepared by the Company without audit in accordance with Securities and Exchange Commission ("SEC") rules for quarterly reports on Form 10-Q. In the opinion of management, all adjustments (which include only normal recurring adjustments) necessary to present fairly the financial position, results of operations, and cash flows at June 30, 2014, and for all periods presented herein, have been made. | |
| Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted. It is suggested that these condensed financial statements be read in conjunction with the financial statements and notes thereto included in the Company's Annual Report on Form 10-K for the year ended December 31, 2013 as filed with the SEC on April 15, 2014. The results of operations for the periods ended June 30, 2014 and 2013 are not necessarily indicative of the operating results for the full years. | |
| Use of Estimates | |
| The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. | |
| Cash and cash equivalents | |
| The Company considers all highly liquid investments with an original maturity of three months or less as cash equivalents. | |
| Inventory | |
| The Company carries inventory of medical equipment and supplies held for resale. Inventory is accounted for on a first–in first-out basis. | |
| Property and equipment | |
| Property and equipment are recorded at cost and depreciated under accelerated or straight line methods over each item's estimated useful life. | |
| Revenue recognition | |
| The Company recognizes revenue using four basic criteria that must be met before revenue can be recognized: (1) persuasive evidence of an arrangement exists; (2) delivery has occurred; (3) the selling price is fixed and determinable; and (4) collectability is reasonably assured. Determination of criteria (3) and (4) are based on management's judgment regarding the fixed nature of the selling prices of the products delivered and the collectability of those amounts. Provisions for discounts and rebates to customers, estimated returns and allowances, and other adjustments are provided for in the same period the related sales are recorded. The Company defers any revenue for which the product has not been delivered or is subject to refund until such time that the Company and the customer jointly determine that the product has been delivered or no refund will be required. | |
| Income tax | |
| The Company accounts for income taxes pursuant to ASC 740. Under ASC 740 deferred taxes are provided on a liability method whereby deferred tax assets are recognized for deductible temporary differences and operating loss carryforwards and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax bases. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment. At June 30, 2014, the Company had net operating loss carryforwards sufficient to offset taxable income. Therefore, the provision for income taxes for the three and six months ended June 30, 2014 and 2013 is $0. | |
| Net income (loss) per share | |
| The Company computes earnings or loss per share in accordance with ASC-260, "Earnings per Share" which requires presentation of both basic and diluted earnings per share on the face of the statement of operations. Basic loss per share is computed by dividing net loss available to common shareholders by the weighted average number of outstanding common shares during the period. Diluted loss per share gives effect to all dilutive potential common shares outstanding during the period. Dilutive loss per share excludes all potential common shares if their effect is anti-dilutive. No potentially dilutive debt or equity instruments were issued or outstanding during the three and six months ended June 30, 2014. | |
| Financial instruments | |
| The carrying value of the Company's financial instruments, as reported in the accompanying balance sheets, approximates fair value. | |
| Long-lived assets | |
| In accordance with ASC 350, the Company regularly reviews the carrying value of intangible and other long-lived assets for the existence of facts or circumstances, both internally and externally, that suggest impairment. If impairment testing indicates a lack of recoverability, an impairment loss is recognized by the Company if the carrying amount of a long-1ived asset exceeds its fair value. | |
| Recent accounting pronouncements | |
| The Company does not believe that any recently issued but not yet adopted accounting pronouncements will have a material impact on its financial position, results of operations or cash flows. |
| 3 COMMON STOCK | 6 Months Ended |
| Jun. 30, 2014 | |
| Accounting Policies [Abstract] | ' |
| COMMON STOCK | ' |
| NOTE 3. COMMON STOCK | |
| During the six months ended June 30, 2014, the Company sold a total of 276,400 shares at $0.25 per share for proceeds of $69,100. |
| 4 NOTES PAYABLE, RELATED PARTIES | 6 Months Ended |
| Jun. 30, 2014 | |
| Debt Disclosure [Abstract] | ' |
| 4 NOTES PAYABLE, RELATED PARTIES | ' |
| NOTE 4. NOTES PAYABLE, RELATED PARTIES | |
| During the six months ended June 30, 2014, the Company repaid the outstanding notes payable to related parties as of December 31, 2013 of $8,500, together with accrued interest of $500. |
| 5 GOING CONCERN | 6 Months Ended |
| Jun. 30, 2014 | |
| Organization, Consolidation and Presentation of Financial Statements [Abstract] | ' |
| 5 GOING CONCERN | ' |
| NOTE 5. GOING CONCERN | |
| The Company has suffered losses from operations and has working capital and stockholders' equity deficits. In all likelihood, the Company will be required to make significant future expenditures in connection with marketing efforts along with general administrative expenses. These conditions raise substantial doubt about the Company's ability to continue as a going concern. | |
| The Company may raise additional capital through the sale of its equity securities, through an offering of debt securities, or through borrowings from financial institutions or related parties. By doing so, the Company hopes to generate sufficient capital to execute its business plan of selling medical supplies on an ongoing basis. Management believes that actions presently being taken to obtain additional funding provide the opportunity for the Company to continue as a going concern. |
| 6 SUBSEQUENT EVENTS | 6 Months Ended |
| Jun. 30, 2014 | |
| Subsequent Events [Abstract] | ' |
| SUBSEQUENT EVENTS | ' |
| NOTE 6. SUBSEQUENT EVENTS | |
| The Company has evaluated subsequent events through the date these financial statements were available to be issued of August 18, 2014 and determined that there are no other reportable subsequent events | |
| 2 SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) | 6 Months Ended |
| Jun. 30, 2014 | |
| Organization, Consolidation and Presentation of Financial Statements [Abstract] | ' |
| Interim Financial Statements | ' |
| NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | |
| Interim Financial Statements | |
| The accompanying financial statements have been prepared by the Company without audit in accordance with Securities and Exchange Commission ("SEC") rules for quarterly reports on Form 10-Q. In the opinion of management, all adjustments (which include only normal recurring adjustments) necessary to present fairly the financial position, results of operations, and cash flows at June 30, 2014, and for all periods presented herein, have been made. | |
| Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted. It is suggested that these condensed financial statements be read in conjunction with the financial statements and notes thereto included in the Company's Annual Report on Form 10-K for the year ended December 31, 2013 as filed with the SEC on April 15, 2014. The results of operations for the periods ended June 30, 2014 and 2013 are not necessarily indicative of the operating results for the full years. | |
| Use of Estimates | |
| The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. | |
| Cash and cash equivalents | |
| The Company considers all highly liquid investments with an original maturity of three months or less as cash equivalents. | |
| Inventory | |
| The Company carries inventory of medical equipment and supplies held for resale. Inventory is accounted for on a first–in first-out basis. | |
| Property and equipment | |
| Property and equipment are recorded at cost and depreciated under accelerated or straight line methods over each item's estimated useful life. | |
| Revenue recognition | |
| The Company recognizes revenue using four basic criteria that must be met before revenue can be recognized: (1) persuasive evidence of an arrangement exists; (2) delivery has occurred; (3) the selling price is fixed and determinable; and (4) collectability is reasonably assured. Determination of criteria (3) and (4) are based on management's judgment regarding the fixed nature of the selling prices of the products delivered and the collectability of those amounts. Provisions for discounts and rebates to customers, estimated returns and allowances, and other adjustments are provided for in the same period the related sales are recorded. The Company defers any revenue for which the product has not been delivered or is subject to refund until such time that the Company and the customer jointly determine that the product has been delivered or no refund will be required. | |
| Income tax | |
| The Company accounts for income taxes pursuant to ASC 740. Under ASC 740 deferred taxes are provided on a liability method whereby deferred tax assets are recognized for deductible temporary differences and operating loss carryforwards and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax bases. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment. At June 30, 2014, the Company had net operating loss carryforwards sufficient to offset taxable income. Therefore, the provision for income taxes for the three and six months ended June 30, 2014 and 2013 is $0. | |
| Net income (loss) per share | |
| The Company computes earnings or loss per share in accordance with ASC-260, "Earnings per Share" which requires presentation of both basic and diluted earnings per share on the face of the statement of operations. Basic loss per share is computed by dividing net loss available to common shareholders by the weighted average number of outstanding common shares during the period. Diluted loss per share gives effect to all dilutive potential common shares outstanding during the period. Dilutive loss per share excludes all potential common shares if their effect is anti-dilutive. No potentially dilutive debt or equity instruments were issued or outstanding during the three and six months ended June 30, 2014. | |
| Financial instruments | |
| The carrying value of the Company's financial instruments, as reported in the accompanying balance sheets, approximates fair value. | |
| Long-lived assets | |
| In accordance with ASC 350, the Company regularly reviews the carrying value of intangible and other long-lived assets for the existence of facts or circumstances, both internally and externally, that suggest impairment. If impairment testing indicates a lack of recoverability, an impairment loss is recognized by the Company if the carrying amount of a long-1ived asset exceeds its fair value. | |
| Recent accounting pronouncements | |
| The Company does not believe that any recently issued but not yet adopted accounting pronouncements will have a material impact on its financial position, results of operations or cash flows. | |
| Use of Estimates | ' |
| Use of Estimates | |
| The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. | |
| Cash and cash equivalents | ' |
| Cash and cash equivalents | |
| The Company considers all highly liquid investments with an original maturity of three months or less as cash equivalents. | |
| Inventory | ' |
| Inventory | |
| The Company carries inventory of medical equipment and supplies held for resale. Inventory is accounted for on a first–in first-out basis. | |
| Property and equipment | ' |
| Property and equipment | |
| Property and equipment are recorded at cost and depreciated under accelerated or straight line methods over each item's estimated useful life. | |
| Revenue recognition | ' |
| Revenue recognition | |
| The Company recognizes revenue using four basic criteria that must be met before revenue can be recognized: (1) persuasive evidence of an arrangement exists; (2) delivery has occurred; (3) the selling price is fixed and determinable; and (4) collectability is reasonably assured. Determination of criteria (3) and (4) are based on management's judgment regarding the fixed nature of the selling prices of the products delivered and the collectability of those amounts. Provisions for discounts and rebates to customers, estimated returns and allowances, and other adjustments are provided for in the same period the related sales are recorded. The Company defers any revenue for which the product has not been delivered or is subject to refund until such time that the Company and the customer jointly determine that the product has been delivered or no refund will be required. | |
| Income tax | ' |
| Income tax | |
| The Company accounts for income taxes pursuant to ASC 740. Under ASC 740 deferred taxes are provided on a liability method whereby deferred tax assets are recognized for deductible temporary differences and operating loss carryforwards and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax bases. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment. At June 30, 2014, the Company had net operating loss carryforwards sufficient to offset taxable income. Therefore, the provision for income taxes for the three and six months ended June 30, 2014 and 2013 is $0. | |
| Net income (loss) per share | ' |
| Net income (loss) per share | |
| The Company computes earnings or loss per share in accordance with ASC-260, "Earnings per Share" which requires presentation of both basic and diluted earnings per share on the face of the statement of operations. Basic loss per share is computed by dividing net loss available to common shareholders by the weighted average number of outstanding common shares during the period. Diluted loss per share gives effect to all dilutive potential common shares outstanding during the period. Dilutive loss per share excludes all potential common shares if their effect is anti-dilutive. No potentially dilutive debt or equity instruments were issued or outstanding during the three and six months ended June 30, 2014. | |
| Financial Instruments | ' |
| Financial instruments | |
| The carrying value of the Company's financial instruments, as reported in the accompanying balance sheets, approximates fair value. | |
| Long-Lived Assets | ' |
| Long-lived assets | |
| In accordance with ASC 350, the Company regularly reviews the carrying value of intangible and other long-lived assets for the existence of facts or circumstances, both internally and externally, that suggest impairment. If impairment testing indicates a lack of recoverability, an impairment loss is recognized by the Company if the carrying amount of a long-1ived asset exceeds its fair value. |
| 3 COMMON STOCK (Details Narrative) (USD $) | 6 Months Ended | |
| Jun. 30, 2014 | Jun. 30, 2013 | |
| Accounting Policies [Abstract] | ' | ' |
| Proceeds from sales of common stock | $69,100 | ' |
| Number of shares sold for proceeds | 276,400 | ' |
| Per share value | $0.25 | ' |
| 4 NOTES PAYABLE, RELATED PARTIES (Details Narrative) (USD $) | 6 Months Ended | |
| Jun. 30, 2014 | Jun. 30, 2013 | |
| Debt Disclosure [Abstract] | ' | ' |
| Amount repaid for notes payable to related parties | $8,500 | ' |
| Accrued interest included in payment | $500 | ' |
